Search Results - "Amat, Karine"

Plasma concentrations of antiretroviral drugs in a successful 4-days-a-week maintenance treatment strategy in HIV-1 patients (ANRS 170-Quatuor trial) by Abe, Emuri, Landman, Roland, Assoumou, Lambert, Amat, Karine, Lambert-Niclot, Sidonie, Bellet, Jonathan, Gibowski, Séverine, Girard, Pierre-Marie, Morand-Joubert, Laurence, de Truchis, Pierre, Alvarez, Jean-Claude

“…Charaterization of the plasma concentrations of antiretrovirals in a 4-days-a-week maintenance treatment strategy in the ANRS-170-QUATUOR study. Patients were…”
Get full text

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL) by Joly, Véronique, Burdet, Charles, Landman, Roland, Vigan, Marie, Charpentier, Charlotte, Katlama, Christine, Cabié, André, Benalycherif, Aida, Peytavin, Gilles, Yeni, Patrick, Mentre, France, Argoud, Anne-Laure, Amri, Imane, Descamps, Diane, Yazdanpanah, Yazdan

“…Abstract Objectives To evaluate the dolutegravir+lamivudine combination in virologically suppressed patients living with HIV. Methods The ANRS 167 LAMIDOL…”
Get full text

HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection by Ghosn, Jade, Assoumou, Lambert, Lascoux-Combe, Caroline, Peytavin, Gilles, Amat, Karine, Gabassi, Audrey, Le, Minh P, Nzalakanda, Robert, Valin, Nadia, Landman, Roland, Chaix, Marie-Laure, Delaugerre, Constance

“…Abstract We compared the proportion of participants achieving first undetectable HIV-1 RNA (VL) in seminal plasma (SP) and blood plasma (BP) in 19 men starting…”
Get full text

Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial by Mazouz, Fella, Bertine, Mélanie, Coppée, Romain, Storto, Alexandre, Katlama, Christine, Landman, Roland, Cabié, André, Peytavin, Gilles, Raffi, François, Yazdanpanah, Yazdan, Descamps, Diane, Joly, Véronique, Ghosn, Jade, Charpentier, Charlotte

“…Hypermutated viruses induced by APOBEC3 (apolipoprotein B mRNA-editing, enzyme-catalytic, polypeptide-like 3) proteins comprise some of the defective viruses…”
Get full text

Pharmacological data of a successful 4‐days‐a‐week regimen in HIV antiretroviral therapy (ANRS 162‐4D trial) by Abe, Emuri, Assoumou, Lambert, Truchis, Pierre, Amat, Karine, Gibowski, Séverine, Gras, Guillaume, Bellet, Jonathan, Saillard, Juliette, Katlama, Christine, Costagliola, Dominique, Girard, Pierre‐Marie, Landman, Roland, Alvarez, Jean‐Claude

“…Introduction Few data are available on plasma concentrations of antiretroviral therapy (ARV) during intermittent treatment. Objective To compare plasma…”
Get full text

Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial by de Truchis, Pierre, Assoumou, Lambert, Landman, Roland, Mathez, Dominique, Le Dû, Damien, Bellet, Jonathan, Amat, Karine, Katlama, Christine, Gras, Guillaume, Bouchaud, Olivier, Duracinsky, Martin, Abe, Emuri, Alvarez, Jean-Claude, Izopet, Jacques, Saillard, Juliette, Melchior, Jean-Claude, Leibowitch, Jacques, Costagliola, Dominique, Girard, Pierre-Marie, Perronne, Christian

“…Intermittent treatment could improve the convenience, tolerability and cost of ART, as well as patients' quality of life. We conducted a 48 week multicentre…”
Get full text

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM) by Meynard, Jean-Luc, Moinot, Laetitia, Landman, Roland, Morand-Joubert, Laurence, Besseghir, Amel, Kolta, Sami, Spire, Bruno, Todesco, Eve, Bouchaud, Olivier, Fagard, Catherine, Chene, Geneviève, Girard, Pierre-Marie

“…Abstract Background Sparing of antiretroviral drug classes could reduce the toxicity and cost of maintenance treatment for HIV infection. Objectives To…”
Get full text